Answers are grounded in this paper and cite their sources.
Analyzes prediction intervals in polygenic score applications, suggesting improved disease risk assessment.
Accurately quantifying uncertainty in predicted phenotypes from polygenic score (PGS)-based applications is essential for reliable clinical interpretation of PGS, supporting effective disease risk assessment and informed decision-making. Here, we present PredInterval, a nonparametric method for constructing well-calibrated prediction intervals. PredInterval is compatible with any PGS method, takes either individual-level data or summary statistics as input and relies on information from quantiles of phenotypic residuals through cross-validation to achieve well-calibrated coverage of true phenotypic values across diverse genetic architectures. We apply PredInterval to analyze 17 traits in real-data applications, where PredInterval not only represents the sole method achieving well-calibrated prediction coverage across traits, but it also offers a principled approach to identify high-risk individuals using prediction intervals, leading to an average improvement of identification rates by 8.7–830.4% compared with existing approaches. Overall, PredInterval represents a robust and versatile tool for enhancing the clinical utility of PGS. PredInterval quantifies phenotype prediction uncertainty in polygenic score-based applications, achieving well-calibrated prediction coverage across 17 traits tested and offering a principled approach to identify high-risk individuals.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: